Publications by authors named "A S Adamovich"

Delineating functionally normal variants from functionally abnormal variants in tumor suppressor proteins is critical for cancer surveillance, prognosis, and treatment options. BRCA1 is a protein that has many variants of uncertain significance which are not yet classified as functionally normal or abnormal. In vitro functional assays can be used to identify the functional impact of a variant when the variant has not yet been categorized through clinical observation.

View Article and Find Full Text PDF

Single nucleotide variants are the most frequent type of sequence changes detected in the genome and these are frequently variants of uncertain significance (VUS). VUS are changes in DNA for which disease risk association is unknown. Thus, methods that classify the functional impact of a VUS can be used as evidence for variant interpretation.

View Article and Find Full Text PDF

Unlabelled: Single nucleotide variants are the most frequent type of sequence changes detected in the genome and these are frequently variants of uncertain significance (VUS). VUS are changes in DNA for which disease risk association is unknown. Thus, methods that classify the functional impact of a VUS can be used as evidence for variant interpretation.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic variants in the BRCA1 gene significantly increase the risk of hereditary breast and ovarian cancer, with many individuals identified carrying variants of uncertain significance (VUSs) through genetic testing.
  • The study assessed 2,271 and 1,427 BRCA1 variants for their roles in homology-directed repair (HDR) and cisplatin resistance (CR) using multiplexed DNA repair assays, revealing high consistency in results.
  • Findings indicate that functional characteristics of these variants align with known clinical significance, providing valuable resources for understanding BRCA1 VUSs and their impact on tumor suppression.
View Article and Find Full Text PDF

The BARD1 protein, which heterodimerizes with BRCA1, is encoded by a known breast cancer susceptibility gene. While several BARD1 variants have been identified as pathogenic, many more missense variants exist that do not occur frequently enough to assign a clinical risk. In this paper, whole exome sequencing of over 10,000 cancer samples from 33 cancer types identified from somatic mutations and loss of heterozygosity in tumors 76 potentially cancer-associated BARD1 missense and truncation variants.

View Article and Find Full Text PDF